中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2012年
16期
1133-1137
,共5页
黄婉兰%李绪渊%王鸿彪%林雯%林文照%林穗玲%林英城
黃婉蘭%李緒淵%王鴻彪%林雯%林文照%林穗玲%林英城
황완란%리서연%왕홍표%림문%림문조%림수령%림영성
二膦酸盐类%紫杉酚%HNE1细胞%细胞增殖%凋亡
二膦痠鹽類%紫杉酚%HNE1細胞%細胞增殖%凋亡
이련산염류%자삼분%HNE1세포%세포증식%조망
Diphosphonates%Paclitaxel%HNE1 cells%Cell roliferation%Apoptosis
目的 探讨唑来膦酸(ZOL)联合紫杉醇(TAX)不同序贯方案对人鼻咽癌低分化鳞癌HNE1细胞系增殖抑制和凋亡诱导作用,寻找两药联合合适序贯给药方式及相关机制.方法 采用四甲基偶氮唑蓝法检测ZOL联合TAX不同序贯用药方案对HNE1细胞的增殖抑制,流式细胞术和Ⅱ原位末端标记法(TUNEL)检测各用药方案对HNE1细胞的凋亡影响,实时定量PCR和Western印迹法测定各用药方案对HNE1细胞Bcl-2、Bax、半胱氨酸天冬氨酸蛋白酶(Caspase)3和Caspase9 mRNA和蛋白表达水平的影响.结果 MTT法提示实验组均能抑制HNE1细胞增殖(P<0.05);其中以ZOL序贯TAX组作用最强(P<0.05).流式细胞术检测早期细胞凋亡,实验组的早期凋亡率则分别为13.89%±0.69% 、11.73%±0.54%、23.97%±0.68%、10.45%±0.16%和8.59%±0.74%,与对照组(2.59%±0.28%)比较,差异均有统计学意义(均P<0.05);TUNEL检测细胞凋亡,实验组均能不同程度增加凋亡率(P<0.05),ZOL序贯TAX组更为明显(P<0.05).实时定量PCR和Western印迹法检测表明用药组均下调抑凋亡蛋白Bcl-2和上调促凋亡蛋白Bax、Caspase9和Caspase3表达;ZOL序贯TAX组更为明显.结论 ZOL能够增强TAX对HNE1增殖抑制和凋亡诱导能力,尤以ZOL序贯TAX作用最强;其机制可能通过影响Bcl-2家族,活化线粒体凋亡途径有关.
目的 探討唑來膦痠(ZOL)聯閤紫杉醇(TAX)不同序貫方案對人鼻嚥癌低分化鱗癌HNE1細胞繫增殖抑製和凋亡誘導作用,尋找兩藥聯閤閤適序貫給藥方式及相關機製.方法 採用四甲基偶氮唑藍法檢測ZOL聯閤TAX不同序貫用藥方案對HNE1細胞的增殖抑製,流式細胞術和Ⅱ原位末耑標記法(TUNEL)檢測各用藥方案對HNE1細胞的凋亡影響,實時定量PCR和Western印跡法測定各用藥方案對HNE1細胞Bcl-2、Bax、半胱氨痠天鼕氨痠蛋白酶(Caspase)3和Caspase9 mRNA和蛋白錶達水平的影響.結果 MTT法提示實驗組均能抑製HNE1細胞增殖(P<0.05);其中以ZOL序貫TAX組作用最彊(P<0.05).流式細胞術檢測早期細胞凋亡,實驗組的早期凋亡率則分彆為13.89%±0.69% 、11.73%±0.54%、23.97%±0.68%、10.45%±0.16%和8.59%±0.74%,與對照組(2.59%±0.28%)比較,差異均有統計學意義(均P<0.05);TUNEL檢測細胞凋亡,實驗組均能不同程度增加凋亡率(P<0.05),ZOL序貫TAX組更為明顯(P<0.05).實時定量PCR和Western印跡法檢測錶明用藥組均下調抑凋亡蛋白Bcl-2和上調促凋亡蛋白Bax、Caspase9和Caspase3錶達;ZOL序貫TAX組更為明顯.結論 ZOL能夠增彊TAX對HNE1增殖抑製和凋亡誘導能力,尤以ZOL序貫TAX作用最彊;其機製可能通過影響Bcl-2傢族,活化線粒體凋亡途徑有關.
목적 탐토서래련산(ZOL)연합자삼순(TAX)불동서관방안대인비인암저분화린암HNE1세포계증식억제화조망유도작용,심조량약연합합괄서관급약방식급상관궤제.방법 채용사갑기우담서람법검측ZOL연합TAX불동서관용약방안대HNE1세포적증식억제,류식세포술화Ⅱ원위말단표기법(TUNEL)검측각용약방안대HNE1세포적조망영향,실시정량PCR화Western인적법측정각용약방안대HNE1세포Bcl-2、Bax、반광안산천동안산단백매(Caspase)3화Caspase9 mRNA화단백표체수평적영향.결과 MTT법제시실험조균능억제HNE1세포증식(P<0.05);기중이ZOL서관TAX조작용최강(P<0.05).류식세포술검측조기세포조망,실험조적조기조망솔칙분별위13.89%±0.69% 、11.73%±0.54%、23.97%±0.68%、10.45%±0.16%화8.59%±0.74%,여대조조(2.59%±0.28%)비교,차이균유통계학의의(균P<0.05);TUNEL검측세포조망,실험조균능불동정도증가조망솔(P<0.05),ZOL서관TAX조경위명현(P<0.05).실시정량PCR화Western인적법검측표명용약조균하조억조망단백Bcl-2화상조촉조망단백Bax、Caspase9화Caspase3표체;ZOL서관TAX조경위명현.결론 ZOL능구증강TAX대HNE1증식억제화조망유도능력,우이ZOL서관TAX작용최강;기궤제가능통과영향Bcl-2가족,활화선립체조망도경유관.
Objective To explore the in vitro effects of anti-proliferation and apoptosis-inducing with different sequence regimens of zoledronic acid plus paclitaxel in human nasopharyngeal carcinoma cell line HNE1 so as to explore the optimal sequence regimen of these two drugs and related mechanism.Methods The cytotoxic effects of different sequence schemes of zoledronic acid plus paclitaxel on HNE1 cells were detected by methyl-thiazol-tetrazolium (MTT) assay.Annexin V-FITC/PI double staining flow cytometry (FCM) and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay were used to measure the effects of zoledronic acid plus paclitaxel upon apoptosis. The expressions of mRNA of Bcl-2,Bax,Caspase3 and Caspase9 gene were detected by real-time quantitativepolymerase chain reaction (PCR) and protein was detected by Western blot. Results All experiment groups enhanced the effect of anti-proliferation by MTT assay( P < 0.05 ) ; the treatment of zoledronic acid followed by paclitaxel was superior to the other two regimens ( P < 0.05 ).As detected by FCM,the early apoptotic rate of control group was 2.59% ± 0.28% and the experiment groups were 13.89% ± 0.69%,11.73% ± 0.54%,23.97% ± 0.68%,10.45% ±0.16% and 8.59% ± 0.74% respectively( P < 0.05).TUNEL assay detected the late apoptosis of HNE1 cells and the experiment groups enhanced the effect of apoptosis-inducing(P < 0.05 ).The treatment of zoledronic acid followed by paclitaxel was superior to the other regimens( P < 0.05 ).Such an effect was due to the down-regulation of anti-apoptotic protein Bcl-2 and up-regulations of pro-apoptotic proteins Bax,Caspase3 and Caspase9 at the expression levels of mRNA and protein.There was a greater regulation in the group of zoledronic acid followed by paclitaxel.Conclusion Zoledronic acid can enhance the in vitro effects of anti-proliferation and apoptosis-inducing for paclitaxel on HNE1 cell.The treatment of zoledronic acid followed by paclitaxel may be the optimal regimen.Synergistic induction of apoptosis is via the effects of Bcl-2 family and through the mitochondrial pathway.